Reimbursement/Privacy Information (continued)
Medicare
Medicare has not established the coverage policy for this test. For Medicare patients, an Advance Beneficiary Notice of Noncoverage (ABN) is required before testing can begin. Because Medicare will not cover test costs until a reimbursement policy has been established, test costs will be billed to the patient. A summary of instructions and documentation requirements for Medicare patients is included on page 1 of the ABN.
You can download the ABN (including Medicare information) form by clicking on the link below. Alternatively, the form can be mailed to you by calling Myriad Customer Service at 1-800-469-4723.
Advanced Beneficiary Notice
Health Insurance Portability and Accountability Act (HIPAA)/Privacy Practices
Myriad Genetic Laboratories, Inc., is dedicated to offering high-quality laboratory services in the area of predictive medicine and is committed to ensuring patient privacy through compliance with HIPAA and applicable state privacy statutes and regulations.
HIPAA, enacted by Congress in 1996, required the Department of Health and Human Services to establish national standards for electronic healthcare transactions and national identifiers for providers, health plans, and employers. In addition, HIPAA also contains provisions that address the security and privacy of health data and information.
Myriad Genetic Laboratories, Inc., has established and maintains an active privacy program that ensures patient confidentiality and is fully compliant with the HIPAA Privacy Rule. As mandated by the Privacy Rule, Myriad Genetic Laboratories, Inc., requires that all employees undergo privacy awareness training and has implemented administrative and technical safeguards that are focused on protecting patient privacy. Myriad is also committed to compliance with the HIPAA Security and the Transactions and Code Sets regulations prior to their respective compliance deadlines. Various states have enacted or issued regulations regarding patient privacy. It is the policy of Myriad Genetic Laboratories, Inc., that test results are disclosed only to the requesting healthcare provider/designee and are not disclosed to anyone else without the written permission of the patient.
Notice of Privacy Practices
The HIPAA Privacy Rule gives individuals the right to be informed of the privacy practices of Myriad Genetic Laboratories, Inc., and their privacy rights regarding their personal health information. The Notice of Privacy Practices can be downloaded in PDF format from the link provided. Alternatively, the Notice of Privacy Practices can be mailed to you by contacting Myriad Customer Service at the number provided below.
Notice of Privacy Practices
Questions
General questions regarding the services offered by Myriad Genetic Laboratories, Inc., should be directed to Myriad Customer Service at 1-800-469-7423.
Complaints
Complaints concerning privacy or confidentiality should be directed to:
Quality and Compliance Department - Privacy Office
E-mail: quality@myriad.com
Phone: 1-801-883-3263
Myriad Genetic Laboratories, Inc.
320 Wakara Way, Salt Lake City, UT 84108
1-800-469-7423 | E-mail: ondose@myriad.com
Myriad, the Myriad logo, OnDose, and the OnDose logo are either trademarks or registered trademarks of Myriad Genetics, Inc., in the United States and other jurisdictions.
